BibTex RIS Kaynak Göster

Moyamoya sendromu olan orak hücreli anemi hastasında tekralayan inmelerin önlenmesi

Yıl 2013, Cilt: 19 Sayı: 3, 205 - 206, 01.04.2013

Süheyl Asma Can Boğa Meliha Tan Mutlu Kasar Mahmut Yeral Şerife Nur Ulusan

https://doi.org/10.5455/GMJ-30-2013-151

Öz

Moyamoya syndrome may occur several years after cerebrovascular event in patients with sickle cell disease. This manuscript presents the efforts to prevent recurrence of stroke by using hydroxyurea and red cell exchange therapy after developing early signs of a new neurological attack in a patient with Moyamoya syndrome.

Anahtar Kelimeler

Moyamoya; sickle cell anemia; stroke; red cell exchange

Kaynakça

  • 1. Dobson SR, Holden KR, Nietert PJ, Cure JK, Laver JH, Disco D, et al. Moyamoya syndrome in childhood sickle cell disease: a predictive factor for recurrent cerebrovascular events. Blood 2002;99(9):3144-50
  • 2. Kim JM, Lee SH, Roh JK. Changing ischaemic lesion patterns in adult moyamoya disease. J Neurol Neurosurg Psychiatry 2009;80(1):36-40
  • 3. Metcalfe SA, Barlow-Stewart K, Campbell J, Emery J. Genetics and blood-hemoglobinopathies and clotting disorders. Aust Fam Physician 2007;36(10):812-9
  • 4. Bhattacharyya M, Kannan M, Chaudhry VP, Mahapatra M, Pati H, Saxena R. Hypercoagulable state in five thalassemia intermedia patients. Clin Appl Thromb Hemost 2007;13(4):422- 7
  • 5. Singh R, Venketesubramanian N. Recurrent cerebral infarction in beta thalassaemia major. Cerebrovasc Dis 2004;17(4):344-5
  • 6. Mukherje A. Moyamoya disease and beta-thalassemia. J Assoc Physicians India 1995;43(10):710-1
  • 7. Sanefuji M, Ohga S, Kira R, Yoshiura T, Torisu H, Hara T
  • Moyamoya syndrome in a splenectomized patient with beta- thalassemia intermedia. J Child Neurol 2006;21(1):75-7
  • 8. Owecki M, Wegrzyn D, Kozubski W. Ischemic manifestation of adult moyamoya disease: a case report. Neurol Neurochir Pol 2003;37(2):419-27
  • 9. Gorrotxategi P, Reguilón MJ, Gaztañaga R. Moya-moya disease in a child with multiple malformations. Rev Neurol 1995;23(120):403-5

Prevention of recurrence of stroke in a patient with sickle cell disease who has Moyamoya Syndrome

Yıl 2013, Cilt: 19 Sayı: 3, 205 - 206, 01.04.2013

Süheyl Asma Can Boğa Meliha Tan Mutlu Kasar Mahmut Yeral Şerife Nur Ulusan

https://doi.org/10.5455/GMJ-30-2013-151

Öz

Moyamoya sendromu orak hücreli anemi hastalarında serebrovasküler olaylardan yıllar sonra gelişebilir. Bu çalışmada yeni bir nörololojik atağın öncü işaretleri gelişen ve Moyamoya sendromu olan hastada, hidroksiüre ve eritrosit değişimi ile inme oluşmasını önleme çabaları sunulmaktadır.

Anahtar Kelimeler

Moyamoya; orak hücreli anemi; inme; eritrosit değişimi

Kaynakça

  • 1. Dobson SR, Holden KR, Nietert PJ, Cure JK, Laver JH, Disco D, et al. Moyamoya syndrome in childhood sickle cell disease: a predictive factor for recurrent cerebrovascular events. Blood 2002;99(9):3144-50
  • 2. Kim JM, Lee SH, Roh JK. Changing ischaemic lesion patterns in adult moyamoya disease. J Neurol Neurosurg Psychiatry 2009;80(1):36-40
  • 3. Metcalfe SA, Barlow-Stewart K, Campbell J, Emery J. Genetics and blood-hemoglobinopathies and clotting disorders. Aust Fam Physician 2007;36(10):812-9
  • 4. Bhattacharyya M, Kannan M, Chaudhry VP, Mahapatra M, Pati H, Saxena R. Hypercoagulable state in five thalassemia intermedia patients. Clin Appl Thromb Hemost 2007;13(4):422- 7
  • 5. Singh R, Venketesubramanian N. Recurrent cerebral infarction in beta thalassaemia major. Cerebrovasc Dis 2004;17(4):344-5
  • 6. Mukherje A. Moyamoya disease and beta-thalassemia. J Assoc Physicians India 1995;43(10):710-1
  • 7. Sanefuji M, Ohga S, Kira R, Yoshiura T, Torisu H, Hara T
  • Moyamoya syndrome in a splenectomized patient with beta- thalassemia intermedia. J Child Neurol 2006;21(1):75-7
  • 8. Owecki M, Wegrzyn D, Kozubski W. Ischemic manifestation of adult moyamoya disease: a case report. Neurol Neurochir Pol 2003;37(2):419-27
  • 9. Gorrotxategi P, Reguilón MJ, Gaztañaga R. Moya-moya disease in a child with multiple malformations. Rev Neurol 1995;23(120):403-5
Toplam 10 adet kaynakça vardır.

Ayrıntılar

Birincil Dil Türkçe
Bölüm Makaleler
Yazarlar

Süheyl Asma Bu kişi benim

Can Boğa Bu kişi benim

Meliha Tan Bu kişi benim

Mutlu Kasar Bu kişi benim

Mahmut Yeral Bu kişi benim

Şerife Nur Ulusan Bu kişi benim

Yayımlanma Tarihi 1 Nisan 2013
Yayımlandığı Sayı Yıl 2013 Cilt: 19 Sayı: 3

Kaynak Göster

APA Asma, S., Boğa, C., Tan, M., Kasar, M., vd. (2013). Prevention of recurrence of stroke in a patient with sickle cell disease who has Moyamoya Syndrome. Gaziantep Medical Journal, 19(3), 205-206. https://doi.org/10.5455/GMJ-30-2013-151
AMA Asma S, Boğa C, Tan M, Kasar M, Yeral M, Ulusan ŞN. Prevention of recurrence of stroke in a patient with sickle cell disease who has Moyamoya Syndrome. Gaziantep Medical Journal. Nisan 2013;19(3):205-206. doi:10.5455/GMJ-30-2013-151
Chicago Asma, Süheyl, Can Boğa, Meliha Tan, Mutlu Kasar, Mahmut Yeral, ve Şerife Nur Ulusan. “Prevention of Recurrence of Stroke in a Patient With Sickle Cell Disease Who Has Moyamoya Syndrome”. Gaziantep Medical Journal 19, sy. 3 (Nisan 2013): 205-6. https://doi.org/10.5455/GMJ-30-2013-151.
EndNote Asma S, Boğa C, Tan M, Kasar M, Yeral M, Ulusan ŞN (01 Nisan 2013) Prevention of recurrence of stroke in a patient with sickle cell disease who has Moyamoya Syndrome. Gaziantep Medical Journal 19 3 205–206.
IEEE S. Asma, C. Boğa, M. Tan, M. Kasar, M. Yeral, ve Ş. N. Ulusan, “Prevention of recurrence of stroke in a patient with sickle cell disease who has Moyamoya Syndrome”, Gaziantep Medical Journal, c. 19, sy. 3, ss. 205–206, 2013, doi: 10.5455/GMJ-30-2013-151.
ISNAD Asma, Süheyl vd. “Prevention of Recurrence of Stroke in a Patient With Sickle Cell Disease Who Has Moyamoya Syndrome”. Gaziantep Medical Journal 19/3 (Nisan 2013), 205-206. https://doi.org/10.5455/GMJ-30-2013-151.
JAMA Asma S, Boğa C, Tan M, Kasar M, Yeral M, Ulusan ŞN. Prevention of recurrence of stroke in a patient with sickle cell disease who has Moyamoya Syndrome. Gaziantep Medical Journal. 2013;19:205–206.
MLA Asma, Süheyl vd. “Prevention of Recurrence of Stroke in a Patient With Sickle Cell Disease Who Has Moyamoya Syndrome”. Gaziantep Medical Journal, c. 19, sy. 3, 2013, ss. 205-6, doi:10.5455/GMJ-30-2013-151.
Vancouver Asma S, Boğa C, Tan M, Kasar M, Yeral M, Ulusan ŞN. Prevention of recurrence of stroke in a patient with sickle cell disease who has Moyamoya Syndrome. Gaziantep Medical Journal. 2013;19(3):205-6.